| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |